Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Nov 2014

Chełstowska Beata, Kuźma-Kozakiewicz Magdalena

Abstract excerpt

UNLABELLED: The cerebrospinal fluid (CSF) used for identification of molecular biomarkers in amyotrophic lateral sclerosis (ALS) is mainly obtained from lumbar puncture (LP) performed to exclude other causes of motor neuron damage. AIM: The aim of the study was to analyze whether CSF of ALS patie...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amyotrophic Lateral Sclerosis
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Predictive Value of Tests

Share to Prognosis

Share to Time Factors

Share to Young Adult

Source

Identifiers

PMID: 25133306
DOI: 10.3109/1354750X.2014.949867

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25133306-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?PMID 25133306Read ↗

Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes.Semantic proximity Read ↗

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseasesSemantic proximity Read ↗

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read ↗

Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cellsSemantic proximity Read ↗

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approachSemantic proximity Read ↗

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.Semantic proximity Read ↗

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.